story of the week
Prognostic Model for Survival of Post-Platinum Patients With Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Journal of Urology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Five-Factor Prognostic Model for Survival of Post-Platinum Patients With Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors
J Urol 2020 Dec 01;204(6)1173-1179, G Sonpavde, J Manitz, C Gao, D Tayama, C Kaiser, D Hennessy, D Makari, A Gupta, SE Abdullah, G Niegisch, JE Rosenberg, DF Bajorin, P Grivas, AB Apolo, R Dreicer, NM Hahn, MD Galsky, A Necchi, S Srinivas, T Powles, TK Choueiri, GR PondFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.